Report Detail
Global Sickle Cell Anemia Therapeutics Market Growth (Status and Outlook) 2019-2024
- RnM3282791 |
- 08 April, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
The classification of Sickle Cell Anemia Therapeutics includes Blood Transfusion, Pharmacotherapy and Bone Marrow Transplant, and the proportion of Blood Transfusion in 2017 is about 45%, and the proportion of Bone Marrow Transplant in 2017 is about 35%.
Sickle Cell Anemia Therapeutics is widely used for child and adult. The most proportion of Sickle Cell Anemia Therapeutics is for child, and the revenue share in 2017 is about 78%.
America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following America, Europe is the second largest consumption place with the consumption market share of 27%.
According to this study, over the next five years the Sickle Cell Anemia Therapeutics market will register a 10.8% CAGR in terms of revenue, the global market size will reach US$ 3620 million by 2024, from US$ 2170 million in 2019. In particular, this report presents the global revenue market share of key companies in Sickle Cell Anemia Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Sickle Cell Anemia Therapeutics market by product type, application, key companies and key regions.
This study considers the Sickle Cell Anemia Therapeutics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Blood Transfusion
Pharmacotherapy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Child
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Sickle Cell Anemia Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Sickle Cell Anemia Therapeutics market by identifying its various subsegments.
Focuses on the key global Sickle Cell Anemia Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sickle Cell Anemia Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Sickle Cell Anemia Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Sickle Cell Anemia Therapeutics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Sickle Cell Anemia Therapeutics Market Size 2014-2024
- 2.1.2 Sickle Cell Anemia Therapeutics Market Size CAGR by Region
- 2.2 Sickle Cell Anemia Therapeutics Segment by Type
- 2.2.1 Blood Transfusion
- 2.2.2 Pharmacotherapy
- 2.2.3 Bone Marrow Transplant
- 2.3 Sickle Cell Anemia Therapeutics Market Size by Type
- 2.3.1 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (2014-2019)
- 2.4 Sickle Cell Anemia Therapeutics Segment by Application
- 2.4.1 Child
- 2.4.2 Adult
- 2.5 Sickle Cell Anemia Therapeutics Market Size by Application
- 2.5.1 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application (2014-2019)
3 Global Sickle Cell Anemia Therapeutics by Players
- 3.1 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Players
- 3.1.1 Global Sickle Cell Anemia Therapeutics Market Size by Players (2017-2019)
- 3.1.2 Global Sickle Cell Anemia Therapeutics Market Size Market Share by Players (2017-2019)
- 3.2 Global Sickle Cell Anemia Therapeutics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Sickle Cell Anemia Therapeutics by Regions
- 4.1 Sickle Cell Anemia Therapeutics Market Size by Regions
- 4.2 Americas Sickle Cell Anemia Therapeutics Market Size Growth
- 4.3 APAC Sickle Cell Anemia Therapeutics Market Size Growth
- 4.4 Europe Sickle Cell Anemia Therapeutics Market Size Growth
- 4.5 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth
5 Americas
- 5.1 Americas Sickle Cell Anemia Therapeutics Market Size by Countries
- 5.2 Americas Sickle Cell Anemia Therapeutics Market Size by Type
- 5.3 Americas Sickle Cell Anemia Therapeutics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Sickle Cell Anemia Therapeutics Market Size by Countries
- 6.2 APAC Sickle Cell Anemia Therapeutics Market Size by Type
- 6.3 APAC Sickle Cell Anemia Therapeutics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Sickle Cell Anemia Therapeutics by Countries
- 7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type
- 7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Sickle Cell Anemia Therapeutics by Countries
- 8.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type
- 8.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Sickle Cell Anemia Therapeutics Market Forecast
- 10.1 Global Sickle Cell Anemia Therapeutics Market Size Forecast (2019-2024)
- 10.2 Global Sickle Cell Anemia Therapeutics Forecast by Regions
- 10.2.1 Global Sickle Cell Anemia Therapeutics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Sickle Cell Anemia Therapeutics Forecast by Type
- 10.8 Global Sickle Cell Anemia Therapeutics Forecast by Application
11 Key Players Analysis
- 11.1 Emmaus Medical
- 11.1.1 Company Details
- 11.1.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Emmaus Medical News
- 11.2 Addmedica
- 11.2.1 Company Details
- 11.2.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.2.3 Addmedica Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Addmedica News
- 11.3 Gamida Cell
- 11.3.1 Company Details
- 11.3.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Gamida Cell News
- 11.4 GlycoMimetics
- 11.4.1 Company Details
- 11.4.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 GlycoMimetics News
- 11.5 Pfizer
- 11.5.1 Company Details
- 11.5.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.5.3 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Pfizer News
- 11.6 Novartis
- 11.6.1 Company Details
- 11.6.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.6.3 Novartis Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Novartis News
- 11.7 Global Blood Therapeutics
- 11.7.1 Company Details
- 11.7.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Global Blood Therapeutics News
- 11.8 Micelle BioPharma
- 11.8.1 Company Details
- 11.8.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Micelle BioPharma News
- 11.9 Bluebird Bio
- 11.9.1 Company Details
- 11.9.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Bluebird Bio News
- 11.10 Prolong Pharmaceuticals
- 11.10.1 Company Details
- 11.10.2 Sickle Cell Anemia Therapeutics Product Offered
- 11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Prolong Pharmaceuticals News
- 11.11 Modus Therapeutics
- 11.12 Sangamo Biosciences
- 11.13 Bioverativ
- 11.14 Imara
- 11.15 Ironwood Pharmaceuticals
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Sickle Cell Anemia Therapeutics . Industry analysis & Market Report on Sickle Cell Anemia Therapeutics is a syndicated market report, published as Global Sickle Cell Anemia Therapeutics Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Sickle Cell Anemia Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
